Central nervous system function modulation via herbal synergy

This entry refers to the *general phenomenon* where herbal medicines, typically composed of multiple bioactive compounds, exert **modulatory effects on CNS function** by targeting various molecular entities—such as **neurotransmitter receptors (GABA₊, dopamine, serotonin, acetylcholine)**, **enzymes (acetylcholinesterase)**, and **signaling pathways (e.g., Nrf2/HO-1, Nrf2/GPX4, calcium signaling)**[1][2][3][4][6]. Synergy arises when constituents in herbal combinations enhance each other's neuropharmacological effects through complementary or overlapping mechanisms, often resulting in neuroprotection, improved cognition, mood regulation, anxiolytic, antidepressant, or hypnotic activities[2][3][4]. Why is this entry incorrect as a canonical target? - It is **not a singular, well-defined molecular entity**, such as a receptor, enzyme, transporter, or gene. - It encompasses a *mechanistic concept* rather than a discrete molecule that can be named, classified, or uniquely targeted. - The effects described result from *complex interactions* with numerous validated CNS targets, not from binding to or modulating a unique structure[1][2][3][4][6]. For structured target information, one must specify an actual molecular target, such as: - GABA₊ receptor - Dopamine D1 receptor - Serotonin 5-HT1A receptor - Acetylcholinesterase These discrete molecules or receptor proteins are legitimate canonical drug targets, each with established molecular data and therapeutic relevance[1][2][4]. The current phrase, however, is *too generic and broad* for canonical target representation.

Other names

Herbal CNS modulationsynergistic neuroprotection by herbsmultitarget herbal therapy for CNS